|Datasheet||Specific References||Reviews||Related Products||Protocols|
The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Rat MPL Gene cDNA Clone (full-length ORF Clone), expression ready, FLAG-tagged||RG80346-G-F|
|Rat MPL Gene cDNA Clone (full-length ORF Clone), expression ready, His-tagged||RG80346-G-H|
|Rat MPL Gene cDNA Clone (full-length ORF Clone), expression ready, Myc-tagged||RG80346-G-M|
|Rat MPL Gene cDNA Clone (full-length ORF Clone), expression ready, untagged||RG80346-G-N|
|Rat MPL Gene cDNA Clone (full-length ORF Clone), expression ready, HA-tagged||RG80346-G-Y|
CD110, also known as c-MPL, is a 635 amino acid transmembrane domain, with two extracellular cytokine receptor domains and two intracellular cytokine receptor box motifs. It is expressed at a low level in a large number of cells of hematopoietic origin. C-MPL is homologous with members of the hematopoietic receptor superfamily. Presence of anti-sense oligodeoxynucleotides of c-mpl inhibited megakaryocyte colony formation. Thrombopoietin is the ligand for c-mpl. It was shown to be the major regulator of megakaryocytopoiesis and platelet formation. Defects in c-MPL are a cause of congenital amegakaryocytic thrombocytopeniawhich is a disease characterized by isolated thrombocytopenia and megakaryocytopenia with no physical anomalies. Defects in c-MPL also cause thrombocythemia type 2 and myelofibrosis with myeloid metaplasia.